Schedule 13D ownership disclosure
EYEGATE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 30233M107
Event date: 2015-02-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,549,650
- Percent of class
- 24.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-013400
- Form type
- SC 13D
- Filer
- KIORA PHARMACEUTICALS INC
- CIK
- CIK 1372514
- Filed
- Mar 02, 2015
- Reporting period
- Feb 19, 2015
- Description
- Schedule 13D beneficial ownership